Fingerprint
Dive into the research topics of 'High-dose therapy with 90yttrium-labeled monoclonal antibody CC49: A phase I trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High-dose therapy with 90yttrium-labeled monoclonal antibody CC49: A phase I trial
Margaret Tempero, Peter Leichner, Janina Baranowska-Kortylewicz, Katherine Harrison, Sam Augustine, Jeffrey Schlom, James Anderson, James Wisecarver, David Colcher
Research output: Contribution to journal › Article › peer-review
62
Scopus
citations